ReviewFrontiers in oncology2022

Biomarkers for risk-based treatment modifications for CNS germ cell tumors: Updates on biological underpinnings, clinical trials, and future directions.

Hirokazu Takami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.